P rospecto : information for the patient
Tramadol/Paracetamol Krka 37.5 mg/325 mg coated tablets EFG
tramadol hydrochloride/paracetamol
Read this prospect carefully before starting to take this medicine because it contains important information for you.
1. What is Tramadol/Paracetamol Krka and for what it is used
2. What you need to know before starting to use Tramadol/Paracetamol Krka
3. How to take Tramadol/Paracetamol Krka
4. Possible adverse effects
Tramadol/Paracetamol Krka is indicated for the symptomatic treatment of moderate to severe pain whenever your doctor believes that the combination of tramadol and paracetamol is necessary.
Tramadol/Paracetamol Krka should be taken by adults and adolescents over 12 years old.
Do not take Tramadol/Paracetamol Krka
Warnings and Precautions
Consult your doctor before starting to take Tramadol/Paracetamol Krka if you:
Tolerance, dependence, and addiction
This medication contains tramadol, which is an opioid medication. Repeated use of opioids can make the medication less effective (you become tolerant of it, known as tolerance). Repeated use of tramadol/paracetamol can also lead to dependence, abuse, and addiction, which can result in a potentially fatal overdose. The risk of these side effects may increase with a higher dose and longer duration of use.
Dependence or addiction can make you feel like you no longer control the amount of medication you need to take or how often you need to take it.
The risk of becoming dependent or addicted to tramadol/paracetamol varies from person to person. You may be at a higher risk of becoming dependent or addicted to tramadol/paracetamol if:
If you notice any of the following signs while taking tramadol/paracetamol, it could be a sign that you have become dependent or addicted:
If you notice any of these signs, talk to your doctor to determine the best course of treatment for you, including when it is appropriate to stop taking it and how to do it safely (see section 3, If you interrupt treatment with tramadol/paracetamol).
Respiratory problems related to sleep
Tramadol/Paracetamol Krka contains an active ingredient that belongs to the opioid group. Opioids can cause respiratory problems related to sleep; for example, central sleep apnea (shallow breathing or pauses in breathing during sleep) and hypoxemia related to sleep (low oxygen levels in the blood).
The risk of experiencing central sleep apnea depends on the dose of opioids. Your doctor may consider reducing the total dose of opioids if you experience central sleep apnea.
There is a weak risk that you may experience a serotonin syndrome that can occur after taking tramadol in combination with certain antidepressants or tramadol alone. Consult your doctor immediately if you experience any of the symptoms associated with this severe syndrome (see section 4 "Possible side effects").
Tramadol is metabolized in the liver by an enzyme. Some people have a variation of this enzyme, and this can affect each person differently. In some people, it may be possible to achieve insufficient pain relief, while others may be more likely to experience severe side effects. If you notice any of the following side effects, stop taking this medication and consult your doctor immediately: slow or shallow breathing, confusion, drowsiness, constricted pupils, general discomfort, or vomiting, constipation, loss of appetite.
If you experience or have experienced any of these problems while taking tramadol/paracetamol, please inform your doctor. They will decide whether you should continue taking this medication.
Children and adolescents
Use in children with respiratory problems
Tramadol should not be used in children with respiratory problems, as the symptoms of tramadol toxicity can worsen in these children.
Consult your doctor if you experience any of the following symptoms while taking this medication:
Extreme fatigue, loss of appetite, severe abdominal pain, nausea, vomiting, or low blood pressure. This may indicate that you have adrenal insufficiency (low cortisol levels). If you experience any of these symptoms, contact your doctor, who will decide if you need to take a hormone supplement.
Other medications and Tramadol/Paracetamol Krka
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Important:This medication contains paracetamol and tramadol. Inform your doctor if you are taking any other medication that contains paracetamol or tramadol, so that you do not exceed the maximum daily dose.
Do not takethis medicationwith monoamine oxidase inhibitors (MAOIs) (see "Do not take Tramadol/Paracetamol Krka").
Do not use Tramadol/Paracetamol Krka if you are being treated with:
Inform your doctor or pharmacist if you are taking:
The risk of side effects increases if you also use:
The effectiveness of Tramadol/Paracetamol Krka may be altered if you also use:
Your doctor will indicate which medications are safe to use with tramadol/paracetamol.
Taking Tramadol/Paracetamol Krka with food and alcohol
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Breastfeeding
Tramadol is excreted in breast milk. For this reason, you should not take this medication more than once while breastfeeding, or alternatively, if you are taking this medication more than once, you should stop breastfeeding.
Fertility
Based on human experience, it is considered that tramadol does not affect female or male fertility. There are no available data on the influence of tramadol and paracetamol on fertility.
Ask your doctor or pharmacist for advice before taking any medication.
Driving and using machines
Tramadol/Paracetamol Krka contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will explain to you what you can expect from the use of tramadol/paracetamol, when and for how long you should take it, when you should contact your doctor and when you should discontinue it (see also section 2).
You should take tramadol/paracetamol for the shortest time possible.
This medication is not recommended for use in children under 12 years old.
The dose should be adjusted to the intensity of the pain and your individual sensitivity. Normally, the lowest dose possible that produces pain relief should be used.
Unless your doctor prescribes otherwise, the recommended starting dose for adults and adolescents over 12 years old is 2 tablets.
If necessary, you can increase the dose as recommended by your doctor. The shortest interval between doses should be at least 6 hours.
Do not take more than 8 tablets per day.
Do not take tramadol/paracetamol more frequently than your doctor has indicated.
Patients over 75 years old
Patients with severe liver or kidney failure/dialysis
Patients with severe renal and/or hepatic failure should not take this medication.
If your liver or kidney failure is mild or moderate, your doctor may recommend prolonging the dosing interval.
Administration route
The tablets should be administered orally.
They should be swallowed whole with sufficient liquid. The tablets should not be broken or chewed.
If you believe the effect of this medication is too strong (e.g., if you feel very drowsy or have difficulty breathing) or too weak (e.g., if you have inadequate pain relief), contact your doctor.
If you take more Tramadol/Paracetamol Krka than you should
In these cases, contact your doctor or pharmacist immediately, even if you feel well.There is a risk of severe liver damage that may only become apparent later.
For accidental ingestion or overdose, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Tramadol/Paracetamol Krka
If you discontinue treatment with Tramadol/Paracetamol Krka
You should not suddenly stop taking this medication unless your doctor advises you to do so. If you want to stop taking your medication, talk to your doctor first, especially if you have been taking it for a long time. Your doctor will advise you when and how to discontinue it, which can be done by gradually reducing the dose to reduce the risk of unnecessary side effects (withdrawal symptoms).
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Not known (frequency unknown):
The following adverse effects recognized have been reported by people who have taken medications containing only tramadol or only paracetamol. However, if you experience any of these symptoms while taking this medicine, you should tell your doctor:
In rare instances, people who have been taking hydrochloride tramadol for some time may feel unwell if they stop treatment abruptly. They may feel agitated, anxious, nervous, or tremulous. They may be hyperactive, have difficulty sleeping, and experience gastrointestinal and intestinal disorders. Very few people may also experience panic attacks, hallucinations, unusual perceptions such as itching, tingling, and numbness, and ear noises (tinnitus). If you experience any of these symptoms after stopping treatment, please consult your doctor.
Serotonin syndrome, which may manifest through changes in mental state (e.g. agitation, hallucinations, coma), and other effects, such as fever, increased heart rate, unstable blood pressure, involuntary muscle contractions, muscle stiffness, lack of coordination, and/or gastrointestinal symptoms (e.g. nausea, vomiting, diarrhea) (see section 2 "What you need to know before taking Tramadol/Paracetamol Krka").
In exceptional cases, blood tests may reveal certain abnormalities, such as low platelet count, which may result in nasal or gum bleeding.
Very rare cases of cutaneous adverse reactions have been described for medications containing paracetamol.
Rare cases of respiratory depression with tramadol have been reported.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano:www.notificaram.es.By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store this medication in a safe and protected place, where other people cannot access it. It may cause serious harm and be fatal to individuals who have not been prescribed it.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Tramadol/Paracetamol Krka
Appearance of Tramadol/Paracetamol Krka and contents of the package
Film-coated tablets, yellow-brown, oval, slightly biconvex.
They are available in packs of 2 film-coated tablets (blister packs with 2 tablets) or 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 film-coated tablets (blister packs with 10 tablets).
Only some pack sizes may be marketed.
Holder of the marketing authorization
KRKA, d.d.,
Novo mesto, Šmarješka cesta 6,
8501 Novo mesto,
Slovenia
Responsible for manufacturing
KRKA, d.d.,
Novo mesto, Šmarješka cesta 6,
8501 Novo mesto,
Slovenia
or
TAD Pharma GmbH,
Heinz-Lohmann-Straße 5,
27472 Cuxhaven,
Germany
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L.,
C/ Anabel Segura 10, Pta. Baja, Oficina 1,
28108 Alcobendas, Madrid,
Spain
This medicine is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
Name of the member state | Name of the medicine |
Germany | Tramabian 37.5 mg/325 mg Filmtabletten |
Austria | Tramadol/Paracetamol Krka 37.5 mg/325 mg Filmtabletten |
Belgium | Tramadol/Paracetamol Krka 37.5 mg/325 mg filmomhulde tabletten |
Hungary | Doreta 37.5mg/325mg filmtabletta |
Bulgaria | Doreta 37.5mg/325mgfilm-coated tablets |
Czech Republic | DORETA |
Estonia | DORETA |
Spain | Tramadol/Paracetamol Krka 37.5 mg/325 mg comprimidos recubiertos con película |
France | Tramadol/Paracetamol Krka 37.5 mg/325 mg comprimé pelliculé |
Ireland | Tramadol/Paracetamol Krka 37.5mg/325mg film-coated tablets |
Italy | Tramadolo e Paracetamolo Krka |
Lithuania | Doreta 37.5mg/325mg plèvele dengtos tabletès |
Latvia | Doreta 37.5mg/325mg apvalkotas tabletes |
Netherlands | Tramadol/Paracetamol Krka 37.5mg/325 mg filmomhulde tabletten |
Poland | Doreta |
United Kingdom (Northern Ireland) | Tramadol hydrochloride/Paracetamol 37.5 mg/325 mg film coated tablets |
Romania | DORETA 37.5mg/325mg, comprimate filmate |
Slovenia | Doreta 37.5mg/325mg filmsko obložene tablete |
Slovakia | Doreta 37.5mg/325mg filmom obalené tablety |
Date of the last review of this leaflet:October 2024
The detailed information about this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.